Pharmacy practice management quarterly最新文献

筛选
英文 中文
Measuring the benefits of clinical decision support: return on investment. 衡量临床决策支持的效益:投资回报。
A H Rosenstein
{"title":"Measuring the benefits of clinical decision support: return on investment.","authors":"A H Rosenstein","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In an effort to provide high quality care in a more cost-effective manner, health care providers have found it necessary to implement a series of decision support strategies designed to improve outcomes of care. While each of these strategies has measurable benefits, they each come along with additional costs. This article will describe a methodology for measuring the costs and direct and indirect benefits from decision support activities.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"20 1","pages":"28-43"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21784939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enforcement spotlight shines on formularies: is your compliance program ready to refute kickback and false claims allegations? 执法焦点集中在公式上:您的合规计划是否准备好反驳回扣和虚假索赔指控?
M S Segall, H H Keuning
{"title":"Enforcement spotlight shines on formularies: is your compliance program ready to refute kickback and false claims allegations?","authors":"M S Segall,&nbsp;H H Keuning","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"20 1","pages":"44-5"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21784940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asthma: an analysis of high-cost patients. 哮喘:高成本患者分析。
D C Malone, K A Lawson, D H Smith
{"title":"Asthma: an analysis of high-cost patients.","authors":"D C Malone,&nbsp;K A Lawson,&nbsp;D H Smith","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To examine characteristics of asthma patients who accounted for 80 percent of national expenditures in 1994 dollars.</p><p><strong>Study design: </strong>Data were extracted from a comprehensive data source, the 1987 National Medical Expenditure Survey (NMES) of approximately 35,000 individuals.</p><p><strong>Patients and methods: </strong>Persons of interest were identified using any occurrence of the ICD-9 code 493 or subcategories. Population weighting factors were used to estimate the population in the United States who sought care for the treatment of asthma. Two groups were identified: a high-cost group, which accounted for 80 percent of the direct medical expenditures, and a low-cost group, which represented 20 percent of expenditures. All analyses were performed using SUDAAN software, which takes into account the complex sampling design used in NMES.</p><p><strong>Results: </strong>Individuals who rated their health as poor or fair were more likely to be in the high-cost group, as compared with those who rated their health as good or excellent (p < .0009). Persons who reported having Medicare, other government, or private insurance were more likely to be in the high-cost group as compared to those with Medicaid and self-pay (p = .01). A person was more likely to be in the high-cost group if he or she used four or more different medications to treat asthma (p < .0001).</p><p><strong>Conclusions: </strong>Persons with asthma are more likely to have greater medical expenditures if they use four or more medications and have deteriorated health status. Managed care organizations and public programs may find these characteristics useful in targeting asthma prevention and management programs.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"20 1","pages":"12-20"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21785092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Measuring the benefits of clinical decision support: return on investment. 衡量临床决策支持的效益:投资回报。
Pharmacy practice management quarterly Pub Date : 2000-04-01 DOI: 10.1097/00004010-199902420-00004
A. Rosenstein
{"title":"Measuring the benefits of clinical decision support: return on investment.","authors":"A. Rosenstein","doi":"10.1097/00004010-199902420-00004","DOIUrl":"https://doi.org/10.1097/00004010-199902420-00004","url":null,"abstract":"In an effort to provide high quality care in a more cost-effective manner, health care providers have found it necessary to implement a series of decision support strategies designed to improve outcomes of care. While each of these strategies has measurable benefits, they each come along with additional costs. This article will describe a methodology for measuring the costs and direct and indirect benefits from decision support activities.","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"20 1 1","pages":"28-43"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61795581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Findings of a three-year retrospective study to investigate prevalence and incidence of urinary incontinence and overactive bladder in a typical managed care setting. 一项为期三年的回顾性研究的结果,调查尿失禁和膀胱过度活动的患病率和发生率在一个典型的管理护理设置。
P L Day
{"title":"Findings of a three-year retrospective study to investigate prevalence and incidence of urinary incontinence and overactive bladder in a typical managed care setting.","authors":"P L Day","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This study was conducted in a large, integrated HMO to determine the prevalence and incidence of urinary incontinence, identify a demographic profile of patients having the UI subgroup condition of overactive bladder, and collect data to create an economic cost of illness description regarding current diagnosis and treatment practices. Using ICD-9 and CPT codes and prescription drug claims data as markers for the disease, subjects were selected for inclusion in the study. Resource use cost data was collected from this cohort over a three-year period and analyzed for total and mean monthly costs.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"20 1","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21785091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
State regulation of pharmacy activities. 国家对药房活动的监管。
{"title":"State regulation of pharmacy activities.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"20 1","pages":"53-65"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21784942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One more time: please fire marginal employees. 再说一遍:请解雇边缘员工。
D H Freed
{"title":"One more time: please fire marginal employees.","authors":"D H Freed","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Managers should not second-guess themselves when contemplating termination of marginal employees, i.e., those with sustained poor attitudes or performances. Poor performers should not be allowed to disadvantage an otherwise successful team; management ought not to retain someone it cannot fully support; and termination may be interpersonally excruciating but is organizationally very invigorating. This article identifies ten reasons why marginal employees prevail and are not dealt with in organizations. Acknowledging these barriers is a valuable first step in moving from analysis to synthesis as concerns removing them in the future.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"20 1","pages":"46-52"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21784941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promising pharmacological agents in the management of acute spinal cord injury. 有前途的药物治疗急性脊髓损伤。
E C Seidl
{"title":"Promising pharmacological agents in the management of acute spinal cord injury.","authors":"E C Seidl","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The search for a pharmacologic treatment of acute spinal cord injury (SCI) dates back to the 1960s. It was not until 1990 that the pharmacologic agent methylprednisolone demonstrated improved outcomes in humans. Methylprednisolone has shown superiority to placebo in humans in two large, multicenter trials, and is the standard of care thus far. Other potentially useful agents include tirilazad, ganglioside (GM-1), and naloxone. Additional studies are needed for these agents to determine the optimal dose and timing of administration.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"20 1","pages":"21-7"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21784938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of managed care on pharmacy practice. 管理式医疗对药房实践的影响。
K W Schafermeyer
{"title":"The impact of managed care on pharmacy practice.","authors":"K W Schafermeyer","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>As prescription drug costs continue their rapid rise, managed care organizations (MCOs) are giving greater attention to containing drug costs. This article examines the impact of managed care on pharmacy practice and reviews types of reimbursement for managed care prescriptions. The author outlines cost-containment measures for MCOs and pharmacy benefit management companies, including the use of mail order pharmacies, electronic claims payment, establishment of formularies, therapeutic interchange and generic incentives, and other measures. Cost-containment steps for pharmacies focus on identifying dispensing costs, decreasing overhead, and reducing ingredient costs. The author recommends that pharmacists begin to demonstrate and establish the value of their cognitive services, especially in patient counseling, in order to obtain reimbursement for these services.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 4","pages":"99-116"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21636215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospital pharmacy data: hospital activity. 医院药房数据:医院活动。
G Lass, J Frandsen
{"title":"Hospital pharmacy data: hospital activity.","authors":"G Lass,&nbsp;J Frandsen","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"19 4","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21637054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信